Pioglitazone decreases diabetes, stroke risks in patients with prediabetes, cerebrovascular disease

Monday, August 01, 2016 by

In insulin-resistant patients with a recent ischemic stroke or transient ischemic attack, pioglitazone was shown to reduce the risk for developing type 2 diabetes and major cardiovascular events, according to an analysis of the IRIS trial.

(Article by healio.com)



Comments

comments powered by Disqus

×
Please like our Facebook Page
Show us your support by liking our page!
Close This Box